NTRA – natera, inc. (US:NASDAQ)

News

Natera, Inc. (NASDAQ: NTRA) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $251.00 price target on the stock.
Natera, Inc. (NASDAQ: NTRA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Natera, Inc. (NASDAQ: NTRA) had its "buy" rating re-affirmed by analysts at BTIG Research.
Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer [Yahoo! Finance]
Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com